Want to see IN:BROOKS full AI Analyst Report?
Brooks Laboratories Limited (BROOKS) Ratios
2 Followers
Brooks Laboratories Limited Ratios
IN:BROOKS's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:BROOKS's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.72 | 1.48 | 1.35 | 0.83 | 1.25 |
| Quick Ratio | 1.21 | 1.08 | 0.93 | 0.49 | 0.69 |
| Cash Ratio | 0.35 | 0.05 | 0.01 | 0.00 | 0.05 |
| Solvency Ratio | 1.03 | -0.33 | -0.72 | -0.39 | -0.19 |
| Operating Cash Flow Ratio | 0.39 | 0.08 | -0.42 | -0.44 | -0.77 |
| Short-Term Operating Cash Flow Coverage | 1.34 | 0.30 | -1.92 | -2.56 | -2.51 |
| Net Current Asset Value | ₹ 118.98M | ₹ 82.87M | ₹ 61.88M | ₹ -81.38M | ₹ -4.09M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.06 | 0.06 | 0.06 | 0.13 |
| Debt-to-Equity Ratio | 0.07 | 0.08 | 0.09 | 0.09 | 0.29 |
| Debt-to-Capital Ratio | 0.06 | 0.07 | 0.08 | 0.08 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.10 |
| Financial Leverage Ratio | 1.21 | 1.26 | 1.38 | 1.48 | 2.24 |
| Debt Service Coverage Ratio | 3.72 | 0.81 | 0.70 | -2.78 | -0.49 |
| Interest Coverage Ratio | 6.55 | 3.25 | 1.42 | -3.16 | 2.50 |
| Debt to Market Cap | 0.07 | 0.02 | 0.02 | 0.04 | 0.13 |
| Interest Debt Per Share | 3.18 | 2.84 | 2.53 | 3.49 | 11.37 |
| Net Debt to EBITDA | 0.04 | 1.09 | 1.32 | -0.22 | -1.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.95% | 16.86% | 28.32% | 20.17% | -8.68% |
| EBIT Margin | 29.65% | 5.11% | 3.02% | -53.46% | -22.81% |
| EBITDA Margin | 31.50% | 7.05% | 5.25% | -46.68% | -14.75% |
| Operating Profit Margin | 6.38% | 4.04% | 1.51% | -11.04% | 8.49% |
| Pretax Profit Margin | 28.67% | -11.86% | -24.62% | -61.42% | -26.21% |
| Net Profit Margin | 28.67% | -12.07% | -24.65% | -33.45% | -21.18% |
| Continuous Operations Profit Margin | 28.67% | -12.07% | -24.65% | -49.69% | -21.18% |
| Net Income Per EBT | 100.00% | 101.79% | 100.13% | 54.46% | 80.81% |
| EBT Per EBIT | 449.44% | -293.39% | -1632.13% | 556.33% | -308.84% |
| Return on Assets (ROA) | 16.59% | -8.06% | -21.66% | -19.07% | -9.86% |
| Return on Equity (ROE) | 20.04% | -10.16% | -29.87% | -28.26% | -22.07% |
| Return on Capital Employed (ROCE) | 4.33% | 3.31% | 1.78% | -9.01% | 5.26% |
| Return on Invested Capital (ROIC) | 4.12% | 3.12% | 1.65% | -6.78% | 3.86% |
| Return on Tangible Assets | 16.59% | -8.06% | -21.68% | -19.10% | -9.89% |
| Earnings Yield | 22.50% | -2.97% | -7.81% | -13.44% | -10.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.32 | 4.13 | 4.87 | 4.79 | 4.79 |
| Payables Turnover | 5.93 | 5.04 | 4.72 | 2.17 | 2.71 |
| Inventory Turnover | 6.15 | 7.46 | 7.59 | 4.48 | 2.75 |
| Fixed Asset Turnover | 5.46 | 5.91 | 5.84 | 4.22 | 0.73 |
| Asset Turnover | 0.58 | 0.67 | 0.88 | 0.57 | 0.47 |
| Working Capital Turnover Ratio | 6.44 | 8.67 | 63.95 | 18.41 | -50.53 |
| Cash Conversion Cycle | 66.37 | 64.89 | 45.73 | -10.77 | 73.88 |
| Days of Sales Outstanding | 68.60 | 88.39 | 74.92 | 76.28 | 76.18 |
| Days of Inventory Outstanding | 59.36 | 48.95 | 48.10 | 81.53 | 132.53 |
| Days of Payables Outstanding | 61.59 | 72.45 | 77.30 | 168.57 | 134.83 |
| Operating Cycle | 127.96 | 137.34 | 123.03 | 157.81 | 208.71 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.92 | 0.58 | -3.78 | -5.81 | -15.01 |
| Free Cash Flow Per Share | 1.73 | -0.03 | -3.95 | -6.00 | -26.08 |
| Dividend Paid and CapEx Coverage Ratio | 2.45 | 0.95 | -22.05 | -31.00 | -1.36 |
| Capital Expenditure Coverage Ratio | 2.45 | 0.95 | -22.05 | -31.00 | -1.36 |
| Operating Cash Flow Coverage Ratio | 1.01 | 0.23 | -1.72 | -2.23 | -1.48 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.02 | -0.12 | -0.23 | -0.41 |
| Free Cash Flow Yield | 4.66% | -0.03% | -4.04% | -9.62% | -35.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 4.44 | -33.66 | -12.80 | -7.44 | -9.42 |
| Price-to-Sales (P/S) Ratio | 1.27 | 4.06 | 3.16 | 2.49 | 1.99 |
| Price-to-Book (P/B) Ratio | 0.89 | 3.42 | 3.82 | 2.10 | 2.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.48 | -3453.08 | -24.78 | -10.40 | -2.80 |
| Price-to-Operating Cash Flow Ratio | 12.72 | 190.26 | -25.91 | -10.73 | -4.86 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.59 | 1.47 | -0.90 | 24.39 |
| Enterprise Value Multiple | 4.08 | 58.68 | 61.42 | -5.55 | -15.20 |
| Enterprise Value | 1.10B | 3.42B | 2.56B | 1.62B | 2.05B |
| EV to EBITDA | 4.08 | 58.68 | 61.42 | -5.55 | -15.20 |
| EV to Sales | 1.29 | 4.14 | 3.22 | 2.59 | 2.24 |
| EV to Free Cash Flow | 21.67 | -3518.32 | -25.33 | -10.83 | -3.14 |
| EV to Operating Cash Flow | 12.83 | 193.85 | -26.48 | -11.18 | -5.46 |
| Tangible Book Value Per Share | 41.66 | 32.40 | 25.57 | 29.57 | 53.59 |
| Shareholders’ Equity Per Share | 41.66 | 32.40 | 25.60 | 29.65 | 35.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.02 | -0.00 | 0.19 | 0.19 |
| Revenue Per Share | 29.12 | 27.27 | 31.03 | 25.05 | 36.55 |
| Net Income Per Share | 8.35 | -3.29 | -7.65 | -8.38 | -7.74 |
| Tax Burden | 1.00 | 1.02 | 1.00 | 0.54 | 0.81 |
| Interest Burden | 0.97 | -2.32 | -8.15 | 1.15 | 1.15 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.13 | 0.05 | 0.16 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.35 | -0.18 | 0.49 | 0.41 | 1.57 |
Currency in INR
